Announced Tue, 21 Jul · 17:04 IST
Board Meeting on 31 July to consider Q1 FY27 results
Results View source PDF
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹673.95
prior close
₹678.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—-0.8-1.1—-1.8-2.4-1.6———————
Up moveDown movePending
AI summary
Astec Lifesciences has informed exchanges that its Board of Directors will meet on Friday, 31 July 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30 June 2026. The results will first be reviewed by the Audit Committee before board approval. The company is part of the Godrej group. No financial numbers have been disclosed in this intimation.
Likely market impact
Investors should watch for Q1 FY27 results on or after 31 July. No specific numbers yet, so no immediate price catalyst from this filing.